Toronto - Delayed Quote
CAD
Eupraxia Pharmaceuticals Inc. (EPRX.TO)
9.71
+0.48
(+5.20%)
At close: November 6 at 4:00:00 PM EST
Loading chart for EPRX.TO
- Previous Close
9.23 - Open
9.26 - Bid 8.70 x --
- Ask 9.83 x --
- Day's Range
9.24 - 9.72 - 52 Week Range
7.70 - 13.08 - Volume
65,563 - Avg. Volume
82,769 - Market Cap (intraday)
641.572M - Beta (5Y Monthly) 1.33
- PE Ratio (TTM)
-- - EPS (TTM)
-1.41 - Earnings Date (est.) Nov 9, 2026
- Forward Dividend & Yield -- (0.00%)
- 1y Target Est
16.33 - Moby Rating Neutral
Recent News
View MorePerformance Overview
Trailing total returns as of 11/6/2026, which may include dividends or other distributions. Benchmark is S&P/TSX Composite index (^GSPTSE) .
YTD Return
EPRX.TO
6.72%
S&P/TSX Composite index (^GSPTSE)
12.31%
1-Year Return
EPRX.TO
21.53%
S&P/TSX Composite index (^GSPTSE)
18.89%
3-Year Return
EPRX.TO
62.92%
S&P/TSX Composite index (^GSPTSE)
80.53%
5-Year Return
EPRX.TO
343.38%
S&P/TSX Composite index (^GSPTSE)
66.80%
Earnings Trends
View MoreAnalyst Insights
View MoreStatistics
View MoreValuation Measures
-
Market Cap
-
Enterprise Value
-
Trailing P/E
-
Forward P/E
-
PEG Ratio (current)
-
Price/Sales (ttm)
-
Price/Book (mrq)
-
Enterprise Value/Revenue
-
Enterprise Value/EBITDA
Financial Highlights
Profitability and Income Statement
-
Profit Margin
0.00%
-
Return on Assets (ttm)
-43.66%
-
Return on Equity (ttm)
-66.70%
-
Revenue (ttm)
--
-
Net Income Avi to Common (ttm)
-52.68M
-
Diluted EPS (ttm)
-1.41
Balance Sheet and Cash Flow
-
Total Cash (mrq)
133.66M
-
Total Debt/Equity (mrq)
1.42%
-
Levered Free Cash Flow (ttm)
-18.93M
